FilingReader Intelligence
Simcere Pharma reports slight revenue rise, adjusted profit soars
March 27, 2025 at 05:35 PM UTC•By FilingReader AI
Simcere Pharmaceutical Group Limited (HKEX:2096) today announced its annual results for the year ended December 31, 2024, reporting revenue of RMB6.635 billion, a 0.4% increase compared to 2023. The growth was primarily fueled by a 3.6% rise in revenue from innovative pharmaceutical products, reaching RMB4.928 billion and constituting 74.3% of total revenue.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
HKEX:2096•Hong Kong Exchange
News Alerts
Get instant email alerts when Simcere Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime